Forsiden ENOVA

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)

News

  • colourbox8759840 International meeting of the Spanish Society for Virology and the Global Virus Network Feb. 15, 2019 6:27 PM

    On behalf of the XV Congress of the Spanish Society of Virology ( Sociedad Española de Virología, SEV) Organizing Committee, it is my great pleasure to welcome you to Barcelona, Spain. The SEV congress will take place on June 9-12 th, 2019 at the Axa Auditorium located in one of the most modern areas of the city. More info here.

    For the first time, the SEV Congress will be organized together with the Global Virus Network (GVN), an international alliance of centers of excellence in the field of human and animal virology ( www.gvn.org); Dr. Christian Bréchot is the president of GVN. This collaboration will increase the scope of our well consolidated SEV Congress and its international visibility.

  • Tetrahedron prize for Creativiy Feb. 14, 2019 1:45 PM

    The Tetrahedron Prize for Creativity in Organic Chemistry was established in 1980 by the Executive Board of Editors and the Publisher of Tetrahedron Publications. It is intended to honour the memory of the founding co-Chairmen of these publications, Professor Sir Robert Robinson and Professor Robert Burns Woodward.

    Deadline for nomination is 31 march 2019

  • TRANSVAC2: “Infectious Diseases Models for Innovative Therapies” Jan. 30, 2019 11:21 AM

    The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” ( IDMIT) are pleased to invite you to a TRANSVAC workshop on “ In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.

  • 3rd call for training modules. Deadline extended to 1 March 2019 Jan. 18, 2019 3:35 PM

    TRANSVAC: European Training in Vaccinology

    The TRANSVAC2 Consortium has set up training modules at leading European centers that can be combined to create customised international courses on vaccine R&D. Two rounds of tailored training courses are planned. Participants can select topics as needed in their field of vaccine development and the timelines of the various modules are harmonized in a way that allows a logical continuation from one topic to the other.

  • 2nd call for ENOVA training school Jan. 18, 2019 3:28 PM

    ENOVA Training School on Immunoactive carbohydrates and adjuvants: antibacterial vaccines from research to clinical trials.

    2nd to 4th April 2019, University of Florence, Italy

    Deadline for applications to be submitted: 22nd February 2019

    Call information and application procedure can be found here

    Send application form to the ENOVA Training School Coordinator ( siobhan.mcclean@ucd.ie) and Co-coordinator (Malgorzata Kesik Brodacka kesikm@iba.waw.pl)

Events

25 Mar.
Geneva, Switzerland

The course provides an overview of state-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines. It combines interactive theoretical parts (lectures and discussion rounds) with practical parts where participants work on different thematic case studies. Invited trainers will present the various adjuvant systems, such as Aluminum salts, Oil-in-Water emulsions, Water-in-Oil emulsions, Liposomes, PLGA particles, Virosomes, QS21, TLR ligands, as well as aspects of preclinical and clinical development of adjuvanted vaccines.For the practical parts, participants will be split into smaller groups. Each group will work on one case study, facilitated by a trainer. The trainer will introduce the case study, provide background information, and explain the tasks and questions for the group work. Following this introduction, each group will work independently on their case study for a given time and will prepare a summary of the case that will be presented to all participants at the end.

29 Mar.
Fontenay-aux-Roses (France)

The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on “In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals. 

29 Mar.
Fontenay-aux-Roses (France)

The EU-funded project TRANSVAC2 and the “Infectious Diseases Models for Innovative Therapies” (IDMIT) are pleased to invite you to a TRANSVAC workshop on

In vivo imaging of host response to vaccines and infections” on 29 March 2019 at the IDMIT research infrastructure at the CEA center of Fontenay-aux-Roses (France). The workshop concentrates on latest advances in new technologies for imaging in living individuals.

This workshop is aimed to present the following topics:

1) Kinetics of vaccines distribution and persistence,

2) Pathogen penetration and dissemination,

3) Host response to vaccines and pathogens exposure.